Kolexia
Tassy Louis
Oncologie médicale
Centre Paoli-Calmettes
Marseille, France
48 Activités
165 Followers

Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Tumeurs du sein Tumeurs du poumon Carcinome pulmonaire à petites cellules Carcinome pulmonaire non à petites cellules Métastase tumorale Sarcomes Tumeurs du cerveau Tumeurs de l'appareil digestif Tumeurs colorectales

Industries

Lilly
3 collaboration(s)
Dernière en 2022
B3TSI
3 collaboration(s)
Dernière en 2023
{{person.topindus3.name}}
{{person.topindus3.tot}} collaboration(s)
Dernière en {{person.topindus3.last}}
{{person.topindus4.name}}
{{person.topindus4.tot}} collaboration(s)
Dernière en {{person.topindus4.last}}

Dernières activités

PROFILER: Program to Establish the Genetic and Immunologic Profile of Patient's Tumor for All Types of Advanced Cancer
Essai Clinique (Centre Léon-Bérard)   01 mars 2024
MOST plus: A Two-period, Multicenter, Randomized, Open-label, Phase II Study Evaluating the Clinical Benefit of a Maintenance Treatment Targeting Tumor Molecular Alterations in Patients With Progressive Locally-advanced or Metastatic Solid Tumors
Essai Clinique (Centre Léon-Bérard)   09 février 2024
Consore: A Powerful Federated Data Mining Tool Driving a French Research Network to Accelerate Cancer Research.
International journal of environmental research and public health   07 février 2024
Triple-negative and Her2-positive breast cancer in women aged 70 and over: prognostic impact of age according to treatment.
Frontiers in oncology   15 décembre 2023
Dysthyroidism during immune checkpoint inhibitors is associated with improved overall survival in adult cancers: data mining of 1385 electronic patient records.
Journal for immunotherapy of cancer   07 août 2023
Dysthyroidism during immune checkpoint inhibitors is associated with improved overall survival in solid tumors: Data-mining of 1,382 electronic patient records.
2022 ASCO Annual Meeting I   02 juin 2022
Feasibility of palbociclib in women aged 70 and older with resistant and/or pretreated advanced breast cancer in the PALOMAGE study
16e Conférence francophone d’Epidémiologie Clinique29è Journées des statisticiens des Centres de Lutte contre le Cancer   01 mai 2022
Abstract P1-18-04: Feasibility of palbociclib in women aged 70 and older with resistant and/or pretreated advanced breast cancer in the PALOMAGE study
2021 San Antonio Breast Cancer Symposium   15 février 2022
E-health, digitalization, or digital transformation: Impact on cancer supportive care.
Bulletin du cancer   19 janvier 2022
Very old patients in multidisciplinary team meeting in PACA: a one-year survey.
Bulletin du cancer   21 septembre 2021